Ibrutinib and FCR chemoimmunotherapy: improving complete remission in CLL patients?
A new prognostic tool for CLL: CLL-IPI
The changing role of nurses in bone marrow biopsies
Exciting current CLL trials taking place in the UK
Exciting results for frontline ibrutinib plus FCR for younger CLL patients